Literature DB >> 2838693

1 alpha,25(OH)2 vitamin D3: a steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms.

L Cancela1, I Nemere, A W Norman.   

Abstract

Vitamin D3 is now considered a pro-hormone and its biological activities are in a great majority due to its hormonally active derivative 1 alpha,25-dihydroxyvitamin D3. The actions of vitamin D3 have been extensively studied both in vivo and in vitro using different animal models as well as a diversity of cell types including intestinal epithelial cells, kidney cells, lymphocytes, macrophages and a number of malignant cell lines. Results thus obtained have considerably extended the number of target tissues for this vitamin and hormone far beyond its classical target organs, parathyroid gland, kidney, intestine and bone. Studies performed at the cellular, subcellular and molecular levels have led to the establishment of new concepts on the mode of action of vitamin D3 which is not believed to act through receptor-mediated genomic and nongenomic events leading to the expression of the full biological response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838693     DOI: 10.1016/0022-4731(88)90073-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  3 in total

Review 1.  Vitamin D nutrition and bone disease in adults.

Authors:  E B Mawer; M Davies
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

Authors:  D D'Ambrosio; M Cippitelli; M G Cocciolo; D Mazzeo; P Di Lucia; R Lang; F Sinigaglia; P Panina-Bordignon
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 3.  The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.

Authors:  F C Campbell; Haibo Xu; M El-Tanani; P Crowe; V Bingham
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.